A Clinical Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and effectiveness of three doses of
vildagliptin, an unapproved drug, compared to placebo in lowering overall blood glucose
levels in people with type 2 diabetes who have not been previously treated with drug therapy
to lower their blood sugar.